Global DNA Synthesis Services and Technologies Market Report (2022 to 2035)

Company logo

Company logo

Dublin, June 21, 2022 (GLOBE NEWSWIRE) – The “DNA Synthesis Services and Technologies Market, Distribution by DNA Synthesis Method, Key Application Areas, Company Size, and Key Geographical Regions: Global Industry Trends and Forecasts, 2022-2035” Report added to ResearchAndMarkets.com Show.

This report features a report that features a detailed study of the current scenario and future potential of DNA synthesis technologies and service providers. Moreover, the study emphasizes an in-depth analysis, highlighting the capabilities of service providers involved in this field.

DNA or RNA molecules find a variety of applications in the biopharmaceutical industry for genetic testing, medical research, therapeutic development, forensic investigation, and other analytical processes. It should be noted that several research studies are being conducted to evaluate the use of oligonucleotides, especially DNA, as a therapeutic intervention to treat various medical conditions.

The approval of the first anti-allergic oligonucleotide drug, Fomivirse, in 1998, increased the demand for DNA-based interventions. In addition to the application of DNA in treatment development, these entities are also published in genetic diagnostics and have already demonstrated use in identifying patients across a variety of diseases including breast cancer, dyslexia, ovarian cancer, Parkinson’s disease and psoriasis.

Advances in medical research have led to the creation of many technologies that can sequence, analyze, and edit different forms of DNA. This, along with the increasing use of DNA across a variety of applications, has prompted industry experts to actively search for efficient DNA synthesis techniques that not only facilitate parallel synthesis of DNA but also provide unparalleled precision, scalability, and speed.

It is noteworthy that several companies have developed proprietary enzymatic DNA synthesis platforms that offer distinct advantages (such as the possibility of increased DNA fragment length, greater accessibility and convenience) over conventional DNA synthesis methods. Due to the well-known advantages of such technologies, a large percentage of medical researchers and treatment/diagnostic developers prefer to outsource DNA synthesis processes to third party platforms/service providers claiming to provide expertise in DNA synthesis and production.

Currently, there are more than 65 players offering DNA synthesis technologies/services, and these players are making active efforts to build/expand their existing capabilities, in order to meet the growing demand for DNA synthesis. Given the growing need for DNA across a wide range of applications, we believe that DNA synthesis platforms and the service industry are likely to experience significant growth for the foreseeable future.

Answer the main questions

  • Who are the leading industry players providing DNA synthesis technologies and services?

  • What are the recent developments and emerging trends in DNA synthesis services and technologies?

  • What partnership models are generally adopted by industry stakeholders in the service industry and DNA synthesis technologies?

  • What are the leading funding organizations that offer scholarships in the DNA synthesis industry?

  • What is the trend of capital investment in the DNA synthesis services and technologies market?

  • What is the focus of various publications related to DNA synthesis technologies and services?

  • How has the DNA synthesis technologies and services market intellectual property landscape evolved over the years?

  • What factors are likely to influence the development of upcoming DNA synthesis technologies and services?

  • How is the current and future opportunity likely to be distributed across key market segments?

Main topics covered:

1. Pave

2. Executive Summary

3. Introduction

4. Market Overview: DNA Assembly Technologies and Services
4.1 Chapter Overview
4.2 DNA synthesis technologies and services: market landscape
4.2.1. Analysis by display type
4.2.2. Analysis by DNA synthesis method
4.2.3. Analysis by type of DNA molecule
4.2.4. Analysis by custom offers
4.2.5. Analysis by field of application
4.3 DNA synthesis technologies and services: major players in the industry
4.3.1 Analysis by year of establishment
4.3.2 Analysis by company size
4.3.3. Headquarters analysis
4.3.4. Analysis by application area and region

5. Company Profiles
5.1 Chapter Overview
5.2 Ajinomoto Bio-Pharma Services
5.2.1. Company Profile
5.2.2. financial information
5.2.3. Technology/Services Portfolio
5.2.4. Recent developments and future outlook
5.3 Atom
5.3.1. Company Profile
5.3.2. Technology/Services Portfolio
5.3.3. Recent developments and future outlook
5.4. DNA text
5.4.1. Company Profile
5.4.2. Technology/Services Portfolio
5.4.3. Recent developments and future outlook
5.5 Eurofins Genomics
5.5.1. Company Profile
5.5.2. financial information
5.5.3. Technology/Services Portfolio
5.5.4. Recent developments and future outlook
5.6 Jane Universal
5.6.1. Company Profile
5.6.2. Technology/Services Portfolio
5.6.3. Recent developments and future outlook
5.7 GeneScript
5.7.1. Company Profile
5.7.2. financial information
5.7.3. Technology/Services Portfolio
5.7.4. Recent developments and future outlook
5.8 Synbio Technologies
5.8.1. Company Profile
5.8.2. Technology/Services Portfolio
5.8.3. Recent developments and future outlook

6. Case Study: Manufacturers of OLIGONUCLEOTIDE (Research and Diagnostic Applications)
6.1 Chapter Overview
6.2 Oligonucleotide manufacturers focused on research and diagnostic applications: the overall market landscape
6.2.1. Analysis by year of establishment
6.2.2. Analysis by company size
6.2.3. Process scale analysis
6.2.4. Analysis by geographic location
6.2.5. Manufacturing facilities site analysis
6.2.6. Analysis of regulatory accreditations/certifications received
6.2.7. Synthesized oligonucleotide type analysis
6.2.8. Analysis by display type
6.2.9. Analysis by type of manufacturing service provided
6.2.10. Analysis by type of modification

7. Case Study: Oligonucleotide Manufacturers (Therapeutic Applications)
7.1 Chapter Overview
7.2 Oligonucleotide Manufacturers Focused On Therapeutic Applications: Market Landscape
7.2.1. Analysis by year of establishment
7.2.2. Analysis by company size
7.2.3. Process scale analysis
7.2.4. Analysis by geographic location
7.2.5. Manufacturing facilities site analysis
7.2.6. Analysis by accreditation/regulatory certifications
7.2.7. Synthesized oligonucleotide type analysis
7.2.8. Analysis by display type
7.2.9. Analysis by type of manufacturing service provided
7.2.10. Analysis by type of modification

8. Partnerships and Collaboration
8.1 Chapter Overview
8.2 Partnership Models
8.3 DNA synthesis technologies and services: a list of partnerships and collaborations
8.3.1. Analysis by year of partnership
8.3.2. Analysis by type of partnership
8.3.3. Analysis by partner type
8.3.4. Analysis by year and partner type
8.3.5. Most Active Players: Analysis by Number of Partnerships
8.3.6. Regional Analysis
8.3.6.1. Transcontinental and transcontinental agreements

9. Financing and investment analysis
9.1 Chapter Overview
9.2. Types of financing
9.3 DNA synthesis techniques: modern financial institutions
9.4 Analysis by investment year
9.5 Analysis of the invested amount
9.5 Analysis of the invested amount
9.6 Analysis by type of financing and the amount invested
9.7 Venture Capital Financing Analysis
9.8. Most Active Players: Analysis by Funding Instances
9.9 Principal Investors: Analysis by Number of Financing Institutions
9.10. Regional analysis by amount invested
9.11. Financing and Investment Summary

10. Grant Analysis
10.1 Chapter Overview
10.2. Analysis methodology and key parameters
10.3. DNA Synthesis Technologies and Services: List of Academic Scholarships
10.3.1. Analysis by grant year
10.3.2. Analysis by grant amount
10.3.3. Institute management center analysis
10.3.4. Analysis by support period
10.3.5. Analysis by managing the center of the institute and the support period
10.3.6. Analysis by type of grant application
10.3.7. Analysis by grant activity code
10.3.8. Word cloud of study titles
10.3.9. Scholarship Purpose Analysis
10.3.10. Divisions of the National Institutes of People’s Health: an analysis by number of grants
10.3.11. Analysis by type of beneficiary organization
10..12. Prominent Program Officers: Analysis by Number of Grants

11. Publication Analysis
11.1. Chapter overview
11.2. Analysis methodology and key parameters
11.3. Analysis by year of publication
11.4. Analysis by quarterly distribution of publication
11.5. Analysis by type of material
11.6. Popular keyword analysis
11.7. Most Popular Authors: Analysis by Number of Publications
11.8 Popular Publishers: Analysis by Number of Publications
11.9 Popular magazines: analysis by number of publications
11.10. Treatment area analysis
11.11. Geographical analysis

12. Patent analysis
12.1. Chapter overview
12.2. Analysis methodology and key parameters
12.3. DNA synthesis services and technologies: patent analysis
12.3.1. Analysis by type of patent
12.3.2. Publication year analysis
12.3.3. Analysis by type of patent and year of publication
12.3.3. Analysis by the issuing authority
12.3.4. Analysis by CPC Codes
12.3.5. Analysis by applicant type
12.3.6. Word Cloud Analysis: Emerging Focus Areas
12.3.7. Industry Leaders: Analysis by Number of Patents
12.3.8. Leading players outside the industry: analysis by number of patents
12.3.9. Leading Players: Analysis by Number of Patents
12.3.10. Leading patents: international patents
12.3.11. Patent Characteristics Analysis
12.3.12. Patent Evaluation Analysis

13. DNA synthesis services: market forecast and opportunity analysis
13.1 Chapter Overview
13.2. Key Assumptions and Forecasting Methodology
13.3. Global DNA Synthesis Services Market, 2022-2035
13.4. North America DNA synthesis services market, 2022-2035
13.5. Europe DNA synthesis services market, 2022-2035
13.6. DNA Synthesis Services Market in Asia Pacific and Rest of the World, 2022-2035

14. Concluding Remarks

15. Annex 1: Tabular data

16. Appendix Two: List of Companies and Institutions

For more information about this report visit https://www.researchandmarkets.com/r/ic5fai

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900